Trial Profile
Identification of Biomarkers for Prediction of Hepatocellular Carcinoma after Elimination of Hepatitis C Virus by Antiviral Medicines, Elbasvir and Grazoprevir
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Jan 2017
Price :
$35
*
At a glance
- Drugs Elbasvir (Primary) ; Grazoprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 12 Jan 2017 New trial record